Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tissue Regenix ( (GB:TRX) ) has shared an update.
Tissue Regenix Group PLC, a UK-based company, announced a change in major holdings due to an acquisition or disposal of voting rights by Lexham Special Opportunities I LP. The transaction resulted in Lexham holding 5.798709% of the voting rights in Tissue Regenix, amounting to 4,140,025 shares. This shift in holdings could potentially impact the company’s shareholder dynamics and influence its decision-making processes.
More about Tissue Regenix
YTD Price Performance: -2.50%
Average Trading Volume: 38,231
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £41.67M
For an in-depth examination of TRX stock, go to TipRanks’ Stock Analysis page.